PHS
PFM Health Sciences’s Caribou Biosciences CRBU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Sell |
1,358,831
-1,147,604
| -46% | -$1.45M | 0.15% | 49 |
|
|
2025
Q1 | $2.29M | Sell |
2,506,435
-1,370,027
| -35% | -$1.25M | 0.17% | 51 |
|
|
2024
Q4 | $6.16M | Sell |
3,876,462
-430,209
| -10% | -$684K | 0.38% | 44 |
|
|
2024
Q3 | $8.44M | Buy |
4,306,671
+223,299
| +5% | +$438K | 0.48% | 42 |
|
|
2024
Q2 | $6.7M | Sell |
4,083,372
-2,399,898
| -37% | -$3.94M | 0.33% | 48 |
|
|
2024
Q1 | $33.3M | Buy |
6,483,270
+2,506
| +0% | +$12.9K | 1.57% | 23 |
|
|
2023
Q4 | $37.1M | Sell |
6,480,764
-243,951
| -4% | -$1.4M | 2.23% | 16 |
|
|
2023
Q3 | $32.1M | Buy |
6,724,715
+1,153,846
| +21% | +$5.52M | 1.51% | 29 |
|
|
2023
Q2 | $23.7M | Buy |
5,570,869
+558,751
| +11% | +$2.37M | 0.92% | 43 |
|
|
2023
Q1 | $26.6M | Buy |
5,012,118
+552,335
| +12% | +$2.93M | 1.18% | 35 |
|
|
2022
Q4 | $28M | Sell |
4,459,783
-1,540,217
| -26% | -$9.67M | 1% | 36 |
|
|
2022
Q3 | $63.3M | Hold |
6,000,000
| – | – | 2.29% | 11 |
|
|
2022
Q2 | $32.6M | Buy |
6,000,000
+1,629,455
| +37% | +$8.85M | 1.24% | 36 |
|
|
2022
Q1 | $40.1M | Buy |
4,370,545
+278,236
| +7% | +$2.55M | 1.5% | 28 |
|
|
2021
Q4 | $59.4M | Hold |
4,092,309
| – | – | 2.02% | 15 |
|
|
2021
Q3 | $88.2M | Buy |
+4,092,309
| New | +$88.2M | 2.59% | 10 |
|